Table 1

Model parameters

Costs
CostSensitivity analysisReference
Drug costs
 ADA, cost per 40 mg syringe$1748$1000–$300016
 IFX, cost per 100 mg unit$1114$500–$150016
 VDZ, cost per 300 mg dose$5788$3000–$900016
Facility costs
 Administration cost of ADA intramuscular injection$2717
 Administration cost of a 3 h IFX infusion$11617
 Administration cost of a 1 h VDZ infusion$7517
Transition probabilities
ProbabilitySensitivity analysisReference
ADA
 Mucosal healing at 8 weeks, 80 mg dosing0.27180.1–0.518–21
 Mucosal healing at 8 weeks, 160 mg dosing0.35640.2–0.618–21
 Mucosal healing at 52 weeks, given week 8 mucosal healing0.30780.2–0.618–21
 Mucosal healing at 52 weeks, given week 8 active disease0.09930.05–0.318–21
IFX
 Mucosal healing at 52 weeks0.36880.2–0.622 23
VDZ
 Clinical response at 6 weeks0.41160.1–0.524 25
 Mucosal healing at 52 weeks, given week 6 response0.44890.2–0.624 25
 Mucosal healing at 52 weeks, given week 6 non-response0.14800.05–0.324 25
  • ADA, adalimumab; IFX, infliximab; VDZ, vedolizumab.